In the last few decades, enzymatic production of 3,4-dihydroxyphenyl-L-alanine (L-dopa) using tyrosine phenol-lyase (Tpl) has been industrialized. This method has an intrinsic problem of tyrosine contamination because Tpl is synthesized under tyrosine-induced conditions. Herein, we constructed a hyper-L-dopa-producing strain by exploiting a mutant TyrR, an activator of tpl. The highest productivity was obtained for the strain grown under non-induced conditions. It was 30-fold higher than that obtained for tyrosine-induced wild-type cells.
3,4-Dihydroxyphenyl-L-alanine (L-dopa) is used in the treatment of Parkinson's disease, which afflicts one out of every 1,700 individuals. Approximately 250 tons of L-dopa is produced per year, nearly half of which is synthesized by an enzymatic method involving tyrosine phenol-lyase (Tpl; EC 4.1.99.2). [1] [2] [3] [4] Tpl, a tyrosineinducible enzyme, normally catalyzes the , -elimination of L-tyrosine to produce pyruvate, ammonia, and phenol. This reaction is reversible, and when catechol is substituted for phenol, L-dopa is produced. 5) Practically, Erwinia herbicola cells with high Tpl activity are prepared by cultivation in a medium supplemented with L-tyrosine, harvested by centrifugation, and then transferred to the reactor together with the substrates (pyruvate, ammonia, and catechol). The synthesized L-dopa precipitates due to its low solubility, which favors the reverse reaction to proceed. This method is very simple and effective, but suffers from contamination by L-tyrosine, which is added as an inducer of Tpl. The structural and chemical similarity between L-dopa and L-tyrosine severely complicates the purification process of L-dopa, which must comply with medicinal standards. Most L-tyrosine added to the medium contaminates the final product, L-dopa, because (i) much of the supplemented L-tyrosine is precipitated due to its low solubility at neutral pHs, and thus is carried over into the reactor with the cells, and (ii) even though L-tyrosine is degraded by Tpl during cultivation, the liberated phenol that remains in the cells is re-converted to L-tyrosine through the reverse reaction of Tpl once L-dopa production is initiated. In order to avoid this drawback, Foor et al. cloned the tpl gene and placed it under the control of a strong promoter in Escherichia coli, but the L-dopa productivity of the recombinant E. coli strain was inferior to that of E. herbicola. 6) Thus, development of a method of eliminating L-tyrosine addition from the current L-dopa production system has long been awaited.
We have elucidated the regulatory mechanism underlying the L-tyrosine-induction of Tpl, and have identified TyrR as the transcriptional activator of tpl. [7] [8] [9] Subsequently, we isolated the tyrR gene from E. herbicola and randomly mutagenized it to obtain a mutant protein with an enhanced ability to activate tpl. One such mutant, TyrR V67A Y72C E201G , was found to increase Tpl expression effectively, 10) and when the mutant gene was introduced into E. herbicola, the resulting strain showed improved L-dopa productivity. 11) However, the addition of L-tyrosine to the medium was still required to achieve the maximum productivity of the strain (Fig. 1B,  tyrR NT , see below).
11)
Recently, we identified second-site suppressor mutations (N324D or A503T) that rescued the inability of TyrR E275Q to activate the tpl promoter. 12) N324 is located in the central domain of TyrR (Fig. 1A) and is thought to be involved in TyrR oligomer formation, which is required for tpl-activation. Amino acid replacement of the residue (N324D) compensated for the impaired ability of TyrR E275Q to form an oligomer. 13) A503 is located in the helix-turn-helix motif of TyrR, and its replacement with threonine (A503T) might affect the DNA-binding property. We hypothesized that accumulation of these amino acid substitutions in the TyrR protein would result in the constitutive expression of Tpl, which might remove the requirement for the addition of L-tyrosine to the medium. Hence, in the y To whom correspondence should be addressed. Fax: +81-76-227-7557; E-mail: hidekuma@ishikawa-pu.ac.jp
Tpl, tyrosine phenol-lyase present study, we accumulated these mutations in various combinations, introduced the resulting mutant tyrR genes into E. herbicola, and then measured the L-dopa productivity of the recombinant strains to assess their efficiency. The constructs of the mutant tyrR genes used in the present study appear in Fig. 1A . The amino acid substitutions that lead to the enhanced Tpl expression were scattered into three domains: V67A, Y72C, and E201G in the N-terminal domain (NT), N324D in the central domain (Cen), and A503T in the C-terminal domain (CT). These mutations were genetically combined by the domains (Fig. 1A) , and the resulting tyrR alleles were inserted into a low-copy-number pSC101-derived plasmid, pTK631 (pSC101 replicon tet þ ).
10)
These plasmids were introduced into tyrR-deficient E. herbicola (ÁtyrR::kan þ ) cells, and the Tpl activity of the cell-free extracts of the recombinant strains was measured using a chromogenic substrate, S-(O-nitrophenyl)-L-cysteine (SOPC). 14) Of the strains tested, those carrying TyrR NT Cen and TyrR NT Cen CT exhibited 32-and 27-fold higher SOPChydrolyzing activity, respectively, when cultivated under non-induced conditions as compared with the wild-type strain. It appears, therefore, that the activity was synergistically enhanced by combining amino acid substitutions in the TyrR protein. Note that SOPC is also a good substrate for tryptophanase, and hence the measured activity might not precisely reflect the Tpl expression level. Next we compared the L-dopa productivity of the recombinant strain carrying TyrR NT Cen or TyrR NT Cen CT with that of the wild-type strain and the recombinant strain carrying TyrR WT or TyrR NT . The cells were cultured for 17 h at 28 C in 100 ml of production medium 15) with and without the addition of 0.2% L-tyrosine in a Sakaguchi flask (shaking flask), and concentrated by centrifugation. No significant difference was observed for the growth rates of the tested strains. The harvested cells were suspended in the 100 ml of reaction mixture comprising 1.6 g of sodium pyruvate, 1.0 g of catechol, 4.7 g of ammonium chloride, 0.13 g of ammonium nitrate, 0.27 g of sodium sulfite, and 0.4 g of disodium ethylenediaminetetraacetic acid, adjusted to pH 8.0 with ammonia just before use. The reaction was carried out for 60 min at 15 C, and was stopped by the addition of HCl. The products were analyzed by HPLC, as described previously.
11)
The recombinant strain carrying TyrR NT showed higher L-dopa productivity than the wild-type strain or the recombinant strain carrying TyrR WT , but the strain still required the addition of L-tyrosine to the medium for maximal L-dopa production (Fig. 1B) , as described previously.
11) The strain with TyrR NT Cen exhibited significantly enhanced ability to produce L-dopa, but again failed to show L-tyrosine-independent L-dopa production. In contrast, the strain carrying TyrR NT Cen CT exhibited the highest L-dopa productivity when cultivated under the non-induced conditions, and its productivity was 30-fold higher than that of the tyrosineinduced wild-type cells that are currently utilized in industrial production (11.1 g/l/h vs. 0.375 g/l/h).
These data suggest that recombinant E. herbicola cells carrying TyrR NT Cen CT are suitable for industrial application, since (i) the high productivity itself is a cost-saving innovation because L-dopa synthesis is conducted in a reactor kept at a low temperature (15 C), (ii) elimination of L-tyrosine addition also leads to cost reduction and substantial simplification of the procedure for L-dopa purification, and (iii) there is no necessity to alter or modify the original plant. The results of the present study also indicate that exploitation of a transcriptional regulator is a promising technique to improve the quality and quantity of a final product in microbial biotechnology.
